SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+1.07%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.36B
AUM Growth
+$1.36B
(+13%)
Cap. Flow
+$221M
Cap. Flow
% of AUM
16.22%
Top 10 Holdings %
Top 10 Hldgs %
57.49%
Holding
75
New
17
Increased
12
Reduced
20
Closed
14
Top Buys
| 1 |
Gilead Sciences
GILD
|
$71.5M |
| 2 |
AbbVie
ABBV
|
$63.9M |
| 3 |
Sarepta Therapeutics
SRPT
|
$52.1M |
| 4 |
Stryker
SYK
|
$41.8M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$38.9M |
Top Sells
| 1 |
Novo Nordisk
NVO
|
$86.5M |
| 2 |
Elanco Animal Health
ELAN
|
$51.7M |
| 3 |
IDEAYA Biosciences
IDYA
|
$17.5M |
| 4 |
Incyte
INCY
|
$13.1M |
| 5 |
Edwards Lifesciences
EW
|
$12.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Disc Medicine
IRON
$2.07B
| $1.44M | 0.11% | 22,752 -18,600 | -45% | -$1.18M |
|
52
Becton Dickinson
BDX
$55.3B
| $1.12M | 0.08% | 4,951 -10,240 | -67% | -$2.32M |
|
53
Vir Biotechnology
VIR
$686M
| $838K | 0.06% | 114,131 -15,115 | -12% | -$111K |
|
54
ICU Medical
ICUI
$3.15B
| $776K | 0.06% | +5,000 | New | +$776K |
|
55
Enliven Therapeutics
ELVN
$1.2B
| $766K | 0.06% | +34,025 | New | +$766K |
|
|
IMA
56
ImageneBio, Inc. Common Stock
IMA
$150M
| $627K | 0.05% | 382,616 | – | – |
|
57
Travere Therapeutics
TVTX
$1.56B
| $568K | 0.04% | +32,616 | New | +$568K |
|
58
Structure Therapeutics
GPCR
$1.11B
| $567K | 0.04% | 20,892 -17,900 | -46% | -$485K |
|
59
Pulmonx
LUNG
$69.7M
| $416K | 0.03% | 61,326 -987 | -2% | -$6.7K |
|
60
Avidity Biosciences
RNA
$5.99B
| $401K | 0.03% | 13,789 -16,683 | -55% | -$485K |
|
61
Astria Therapeutics
ATXS
$349M
| – | – | -85,640 | Closed | -$943K |
|
62
Cabaletta Bio
CABA
$133M
| – | – | -1,533,883 | Closed | -$7.24M |
|
63
Perspective Therapeutics
CATX
$250M
| – | – | -120,632 | Closed | -$1.61M |
|
|
64
Elanco Animal Health
ELAN
$9.12B
| – | – | -3,518,684 | Closed | -$51.7M |
|
65
Guardant Health
GH
$8.41B
| – | – | -406,645 | Closed | -$9.33M |
|
66
Illumina
ILMN
$15.8B
| – | – | -40,611 | Closed | -$5.3M |
|
|
IMTXW
67
DELISTED
Immatics N.V. Warrants
IMTXW
| – | – | -366,568 | Closed | -$852K |
|
68
Kura Oncology
KURA
$686M
| – | – | -296,884 | Closed | -$5.8M |
|
|
69
Novo Nordisk
NVO
$251B
| – | – | -726,329 | Closed | -$86.5M |
|
70
Novartis
NVS
$245B
| – | – | 0 | – | – |
|
71
Phibro Animal Health
PAHC
$1.5B
| – | – | -238,184 | Closed | -$5.36M |
|
72
Revolution Medicines
RVMD
$7.1B
| – | – | -203,271 | Closed | -$9.22M |
|
73
TG Therapeutics
TGTX
$4.65B
| – | – | -358,644 | Closed | -$8.39M |
|
74
Thermo Fisher Scientific
TMO
$186B
| – | – | -5,770 | Closed | -$3.57M |
|
|
MRNS
75
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| – | – | -4,386,177 | Closed | -$7.72M |
|